MedTrace Logo

Multicentric Risk Evaluation of Autologous Fat Grafting Procedure

NCT04130373 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6510

Last updated 2019-10-30

No results posted yet for this study

Summary

Autologous fat grafting, also known as lipofilling, is a surgical technique consisting in the processing and transfer of adipose tissue from one area in our organism (hips, thighs) to region which in need of reconstructive and aesthetic correction. The technique is frequently used after radical or conservative mammary surgery, aiming to achieve better aesthetic results, reduce pain induced by both surgery and radiotherapy. The scientific community was widely involved in the debate regarding the use of mesenchymal/stem cells in a patient with high risk of tumor progression due to their elevated proliferative profile. This study aims to retrospectively evaluate the oncological safety in the use of lipofilling in patients who underwent oncological and reconstructive treatment in our Institute.

Conditions

  • Pain, Postoperative

Interventions

PROCEDURE

Autologous fat grafting procedure

Surgical intervention based on the injection of autologous fat grafting after radical or conservative breast surgery and breast reconstruction.

PROCEDURE

Breast reconstruction

Breast reconstructive procedures after oncological radical or conservative breast surgery

Sponsors & Collaborators

  • Humanitas Clinical and Research Center

    lead OTHER

Principal Investigators

  • Marco Klinger, MD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-01-31
Completion
2020-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130373 on ClinicalTrials.gov